A novel bitriazolyl acyclonucleoside endowed with dual antiproliferative and immunomodulatory activity - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Medicinal Chemistry Année : 2012

A novel bitriazolyl acyclonucleoside endowed with dual antiproliferative and immunomodulatory activity

O. Demaria
  • Fonction : Auteur
J. Tang
  • Fonction : Auteur
P. Rocchi
  • Fonction : Auteur
F. Qu
  • Fonction : Auteur
J.L. Iovanna
  • Fonction : Auteur
L. Alexopoulou
  • Fonction : Auteur

Résumé

A novel bitriazolyl acyclonucleoside was discovered to exhibit powerful antiproliferative effects on different cancer cell lines through caspase-dependent apoptosis and at the same time stimulate the immune response in dendritic cells via Toll-like receptor 7 (TLR7) signaling. This promising compound with dual anticancer and immunomodulatory activity may represent a new generation of highly efficacious drug candidates for use in cancer therapy

Domaines

Chimie

Dates et versions

hal-00724325 , version 1 (20-08-2012)

Identifiants

Citer

Y. Xia, M. Wang, O. Demaria, J. Tang, P. Rocchi, et al.. A novel bitriazolyl acyclonucleoside endowed with dual antiproliferative and immunomodulatory activity. Journal of Medicinal Chemistry, 2012, 55 (11), pp.5642-5646. ⟨10.1021/jm300534u⟩. ⟨hal-00724325⟩
18 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More